HRP20090343T1 - Novel carbamylated epo and method for its production - Google Patents
Novel carbamylated epo and method for its productionInfo
- Publication number
- HRP20090343T1 HRP20090343T1 HR20090343T HRP20090343T HRP20090343T1 HR P20090343 T1 HRP20090343 T1 HR P20090343T1 HR 20090343 T HR20090343 T HR 20090343T HR P20090343 T HRP20090343 T HR P20090343T HR P20090343 T1 HRP20090343 T1 HR P20090343T1
- Authority
- HR
- Croatia
- Prior art keywords
- production
- novel
- carbamylated epo
- novel carbamylated
- epo
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 108700001003 carbamylated erythropoietin Proteins 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58637004P | 2004-07-07 | 2004-07-07 | |
DKPA200401075 | 2004-07-07 | ||
US69387005P | 2005-06-23 | 2005-06-23 | |
PCT/DK2005/000477 WO2006002646A2 (en) | 2004-07-07 | 2005-07-07 | Novel carbamylated epo and method for its production |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20090343T1 true HRP20090343T1 (en) | 2009-07-31 |
Family
ID=34979159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20090343T HRP20090343T1 (en) | 2004-07-07 | 2009-06-15 | Novel carbamylated epo and method for its production |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1781697B1 (xx) |
JP (1) | JP5025470B2 (xx) |
AT (1) | ATE429444T1 (xx) |
AU (1) | AU2005259689B2 (xx) |
BR (1) | BRPI0513029A (xx) |
CA (1) | CA2572643A1 (xx) |
CY (1) | CY1109232T1 (xx) |
DE (1) | DE602005014117D1 (xx) |
DK (1) | DK1781697T3 (xx) |
EA (1) | EA011586B1 (xx) |
ES (1) | ES2325034T3 (xx) |
HK (1) | HK1109631A1 (xx) |
HR (1) | HRP20090343T1 (xx) |
IL (1) | IL180518A0 (xx) |
MX (1) | MXPA06014742A (xx) |
NO (1) | NO20070687L (xx) |
PL (1) | PL1781697T3 (xx) |
PT (1) | PT1781697E (xx) |
SI (1) | SI1781697T1 (xx) |
WO (1) | WO2006002646A2 (xx) |
Families Citing this family (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7718363B2 (en) | 2003-04-25 | 2010-05-18 | The Kenneth S. Warren Institute, Inc. | Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds |
EP1771190A4 (en) * | 2004-07-02 | 2009-07-22 | Kenneth S Warren Inst Inc | METHOD FOR THE PRODUCTION OF COMPLETELY CARBAMYLATED ERYTHROPOIETIN |
DE102006004008A1 (de) * | 2006-01-27 | 2007-08-02 | Hannelore Prof. Dr. Dr. Ehrenreich | Verfahren zur Behandlung und/oder Prophylaxe von Multipler Sklerose, sowie Verwendung von Erythropoietin zur Herstellung eines Arzneimittels zur intermittierenden Behandlung und/oder intermittierenden Prophylaxe von Multipler Sklerose |
US7811560B2 (en) * | 2006-01-30 | 2010-10-12 | Auxilium Us Holdings, Llc | Compositions and methods for treating collagen-mediated diseases |
ES2327170T3 (es) * | 2007-02-22 | 2009-10-26 | Polymun Scientific Immunbiologische Forschung Gmbh | Proteina de fusion de eritropoyetina. |
AR065613A1 (es) * | 2007-03-09 | 2009-06-17 | Chugai Pharmaceutical Co Ltd | Agentes de proteccion para organos transplantados |
ES2750254T3 (es) | 2007-09-27 | 2020-03-25 | Amgen Inc | Formulaciones farmacéuticas |
WO2009064838A1 (en) | 2007-11-15 | 2009-05-22 | Amgen, Inc. | Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration |
EP2803675A3 (en) | 2008-01-25 | 2014-12-24 | Amgen, Inc | Ferroportin antibodies and methods of use |
US9315577B2 (en) | 2008-05-01 | 2016-04-19 | Amgen Inc. | Anti-hepcidin antibodies and methods of use |
DK2342223T3 (en) | 2008-09-26 | 2017-07-24 | Ambrx Inc | Modified animal erythropoietin polypeptides and their uses |
WO2010056981A2 (en) | 2008-11-13 | 2010-05-20 | Massachusetts General Hospital | Methods and compositions for regulating iron homeostasis by modulation bmp-6 |
EP2490957B1 (en) | 2009-10-23 | 2016-11-23 | Amgen, Inc | Vial adapter and system |
TW201129374A (en) | 2009-10-26 | 2011-09-01 | Lundbeck & Co As H | Use of carbamylated erythropoietin for the treatment of Friedreich's ataxia |
TW201129375A (en) | 2009-11-18 | 2011-09-01 | Lundbeck & Co As H | Treatment of acute ischemic stroke or intracranial bleeding with tPa and carbamylated erythropoietin |
HUE026173T2 (en) | 2010-06-07 | 2016-05-30 | Amgen Inc | pharmaceutical Pump |
TW201213807A (en) | 2010-07-19 | 2012-04-01 | Lundbeck & Co As H | Bioassay for the measurement of CEPO concentration and activity |
WO2012069474A2 (en) | 2010-11-24 | 2012-05-31 | H. Lundbeck A/S | A method for reducing potential virus burden in a sample by cyanate treatment |
AU2012236573B2 (en) | 2011-03-31 | 2016-06-02 | Amgen Inc. | Vial adapter and system |
DK2699293T3 (en) | 2011-04-20 | 2019-04-29 | Amgen Inc | AUTO INJECTION DEVICE |
MX357209B (es) | 2011-10-14 | 2018-06-29 | Amgen Inc | Inyector y metodo de ensamble. |
HUE057423T2 (hu) | 2012-01-12 | 2022-05-28 | Endo Global Ventures | Clostridium histolyticum enzim |
ES2780395T3 (es) | 2012-11-21 | 2020-08-25 | Amgen Inc | Dispositivo de administración de fármacos |
EP2968775B1 (en) | 2013-03-15 | 2019-12-18 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
ES2973257T3 (es) | 2013-03-15 | 2024-06-19 | Amgen Inc | Casete de fármaco, autoinyector y sistema de autoinyector |
MX359794B (es) | 2013-03-15 | 2018-10-10 | Intrinsic Lifesciences Llc | Anticuerpos anti-hepcidina y usos de los mismos. |
LT2976117T (lt) | 2013-03-22 | 2021-02-25 | Amgen Inc. | Purkštuvas ir surinkimo būdas |
CN105873626A (zh) | 2013-10-24 | 2016-08-17 | 美国安进公司 | 注射器和组装方法 |
US10758683B2 (en) | 2013-10-24 | 2020-09-01 | Amgen Inc. | Drug delivery system with temperature-sensitive control |
US10994112B2 (en) | 2014-02-05 | 2021-05-04 | Amgen Inc. | Drug delivery system with electromagnetic field generator |
US10722655B2 (en) | 2014-05-07 | 2020-07-28 | Amgen Inc. | Autoinjector with shock reducing elements |
JP6822843B2 (ja) | 2014-06-03 | 2021-01-27 | アムジエン・インコーポレーテツド | 薬物送達装置によって収集されたデータを遠隔で処理するためのシステム及び方法 |
WO2016049036A1 (en) | 2014-09-22 | 2016-03-31 | Intrinsic Lifesciences Llc | Humanized anti-hepcidin antibodies and uses thereof |
EP3943135A3 (en) | 2014-10-14 | 2022-06-29 | Amgen Inc. | Drug injection device with visual and audible indicators |
US10799630B2 (en) | 2014-12-19 | 2020-10-13 | Amgen Inc. | Drug delivery device with proximity sensor |
EP3689394A1 (en) | 2014-12-19 | 2020-08-05 | Amgen Inc. | Drug delivery device with live button or user interface field |
CA2976935C (en) | 2015-02-17 | 2020-03-10 | Amgen Inc. | Drug delivery device with vacuum assisted securement and/or feedback |
EP3261690B1 (en) | 2015-02-27 | 2021-12-15 | Amgen Inc. | Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement |
WO2017039786A1 (en) | 2015-09-02 | 2017-03-09 | Amgen Inc. | Syringe assembly adapter for a syringe |
JP7082568B2 (ja) | 2015-12-09 | 2022-06-08 | アムジエン・インコーポレーテツド | 信号伝達キャップ付き自動注射器 |
US11154661B2 (en) | 2016-01-06 | 2021-10-26 | Amgen Inc. | Auto-injector with signaling electronics |
EP3721922B1 (en) | 2016-03-15 | 2022-05-04 | Amgen Inc. | Reducing probability of glass breakage in drug delivery devices |
WO2017189089A1 (en) | 2016-04-29 | 2017-11-02 | Amgen Inc. | Drug delivery device with messaging label |
US11389588B2 (en) | 2016-05-02 | 2022-07-19 | Amgen Inc. | Syringe adapter and guide for filling an on-body injector |
AU2017263558B2 (en) | 2016-05-13 | 2022-12-22 | Amgen Inc. | Vial sleeve assembly |
EP3458988B1 (en) | 2016-05-16 | 2023-10-18 | Amgen Inc. | Data encryption in medical devices with limited computational capability |
US11541176B2 (en) | 2016-06-03 | 2023-01-03 | Amgen Inc. | Impact testing apparatuses and methods for drug delivery devices |
US11285266B2 (en) | 2016-07-01 | 2022-03-29 | Amgen Inc. | Drug delivery device having minimized risk of component fracture upon impact events |
US20190328965A1 (en) | 2016-08-17 | 2019-10-31 | Amgen Inc. | Drug delivery device with placement detection |
WO2018081234A1 (en) | 2016-10-25 | 2018-05-03 | Amgen Inc. | On-body injector |
WO2018136398A1 (en) | 2017-01-17 | 2018-07-26 | Amgen Inc. | Injection devices and related methods of use and assembly |
US11752258B2 (en) | 2017-02-17 | 2023-09-12 | Amgen Inc. | Drug delivery device with sterile fluid flowpath and related method of assembly |
AU2018221351B2 (en) | 2017-02-17 | 2023-02-23 | Amgen Inc. | Insertion mechanism for drug delivery device |
CA3055041A1 (en) | 2017-03-01 | 2018-09-07 | Endo Ventures Limited | Apparatus and method for assessing and treating cellulite |
JP2020508803A (ja) | 2017-03-06 | 2020-03-26 | アムジエン・インコーポレーテツド | 作動防止特徴部を備える薬物送達デバイス |
SG11201908058UA (en) | 2017-03-07 | 2019-09-27 | Amgen Inc | Needle insertion by overpressure |
EP3592404A1 (en) | 2017-03-09 | 2020-01-15 | Amgen Inc. | Insertion mechanism for drug delivery device |
WO2018172219A1 (en) | 2017-03-20 | 2018-09-27 | F. Hoffmann-La Roche Ag | Method for in vitro glycoengineering of an erythropoiesis stimulating protein |
FI3600491T3 (fi) | 2017-03-28 | 2023-10-20 | Amgen Inc | Männänvarren ja ruiskukokoonpanon järjestelmä ja menetelmä |
BR112019020394A2 (pt) | 2017-03-28 | 2020-04-22 | Endo Ventures Ltd | método melhorado de produção de colagenase |
AU2018280054B2 (en) | 2017-06-08 | 2023-07-13 | Amgen Inc. | Syringe assembly for a drug delivery device and method of assembly |
JP7200134B2 (ja) | 2017-06-08 | 2023-01-06 | アムジエン・インコーポレーテツド | トルク駆動式薬物送達デバイス |
EP3641857A1 (en) | 2017-06-22 | 2020-04-29 | Amgen Inc. | Device activation impact/shock reduction |
MA49461A (fr) | 2017-06-23 | 2020-04-29 | Amgen Inc | Dispositif électronique d'administration de médicament comprenant un bouchon activé par un ensemble commutateur |
ES2972207T3 (es) | 2017-07-14 | 2024-06-11 | Amgen Inc | Sistema de inserción-retracción de agujas con sistema de resorte de torsión doble |
EP4292576A3 (en) | 2017-07-21 | 2024-01-17 | Amgen Inc. | Gas permeable sealing member for drug container and methods of assembly |
MA49676A (fr) | 2017-07-25 | 2020-06-03 | Amgen Inc | Dispositif d'administration de médicament doté d'un système d'accès à un récipient et procédé d'assemblage associé |
EP3658203B1 (en) | 2017-07-25 | 2022-08-31 | Amgen Inc. | Drug delivery device with gear module and related method of assembly |
MA49838A (fr) | 2017-08-09 | 2020-06-17 | Amgen Inc | Systèm de administration de médicaments avec pression hydraulique-pneumatique de chambre |
EP3668567A1 (en) | 2017-08-18 | 2020-06-24 | Amgen Inc. | Wearable injector with sterile adhesive patch |
US11103636B2 (en) | 2017-08-22 | 2021-08-31 | Amgen Inc. | Needle insertion mechanism for drug delivery device |
MA50611A (fr) | 2017-10-04 | 2020-08-12 | Amgen Inc | Adaptateur d'écoulement destiné à un dispositif d'administration de médicament |
CN111132711B (zh) | 2017-10-06 | 2022-07-01 | 安进公司 | 带有联锁组件的药物递送装置及相关组装方法 |
IL273323B1 (en) | 2017-10-09 | 2024-06-01 | Amgen Inc | Drug delivery device with drive assembly and related assembly method |
US11826480B2 (en) | 2017-11-03 | 2023-11-28 | Amgen Inc. | Systems and approaches for sterilizing a drug delivery device |
WO2019089178A1 (en) | 2017-11-06 | 2019-05-09 | Amgen Inc. | Drug delivery device with placement and flow sensing |
EP3707075A1 (en) | 2017-11-06 | 2020-09-16 | Amgen Inc. | Fill-finish assemblies and related methods |
MA50557A (fr) | 2017-11-10 | 2020-09-16 | Amgen Inc | Pistons pour dispositifs d'administration de médicament |
WO2019099324A1 (en) | 2017-11-16 | 2019-05-23 | Amgen Inc. | Door latch mechanism for drug delivery device |
MX2020005066A (es) | 2017-11-16 | 2020-08-20 | Amgen Inc | Autoinyector con deteccion de detencion y punto final. |
US10835685B2 (en) | 2018-05-30 | 2020-11-17 | Amgen Inc. | Thermal spring release mechanism for a drug delivery device |
US11083840B2 (en) | 2018-06-01 | 2021-08-10 | Amgen Inc. | Modular fluid path assemblies for drug delivery devices |
US20210228815A1 (en) | 2018-07-24 | 2021-07-29 | Amgen Inc. | Hybrid drug delivery devices with grip portion |
WO2020023451A1 (en) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Delivery devices for administering drugs |
MX2021000748A (es) | 2018-07-24 | 2021-03-26 | Amgen Inc | Dispositivos de suministro para administrar farmacos. |
WO2020023220A1 (en) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Hybrid drug delivery devices with tacky skin attachment portion and related method of preparation |
EP3829692A1 (en) | 2018-07-31 | 2021-06-09 | Amgen Inc. | Fluid path assembly for a drug delivery device |
CA3106452A1 (en) | 2018-09-24 | 2020-04-02 | Amgen Inc. | Interventional dosing systems and methods |
WO2020068476A1 (en) | 2018-09-28 | 2020-04-02 | Amgen Inc. | Muscle wire escapement activation assembly for a drug delivery device |
CA3110529A1 (en) | 2018-10-02 | 2020-04-09 | Amgen Inc. | Injection systems for drug delivery with internal force transmission |
JP2022503989A (ja) | 2018-10-05 | 2022-01-12 | アムジエン・インコーポレーテツド | 投薬量インジケータを有する薬物送達デバイス |
CA3109988A1 (en) | 2018-10-15 | 2020-04-23 | Amgen Inc. | Platform assembly process for drug delivery device |
KR20210076935A (ko) | 2018-10-15 | 2021-06-24 | 암젠 인크 | 댐핑 메커니즘을 갖는 약물 전달 장치 |
TWI831847B (zh) | 2018-11-01 | 2024-02-11 | 美商安進公司 | 部分針頭縮回之藥物遞送裝置及其操作方法 |
US20220031939A1 (en) | 2018-11-01 | 2022-02-03 | Amgen Inc. | Drug delivery devices with partial drug delivery member retraction |
US11213620B2 (en) | 2018-11-01 | 2022-01-04 | Amgen Inc. | Drug delivery devices with partial drug delivery member retraction |
MX2021012557A (es) | 2019-04-24 | 2021-11-12 | Amgen Inc | Conjuntos y metodos de verificacion de esterilizacion de jeringuillas. |
MX2022002149A (es) | 2019-08-23 | 2022-03-17 | Amgen Inc | Dispositivo de suministro de farmacos con componentes de acoplamiento de capuchon de aguja configurable y metodos relacionados. |
RU2720103C1 (ru) * | 2019-10-16 | 2020-04-24 | Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") | Способ коррекции нарушений микроциркуляции в плаценте карбамилированным дарбэпоэтином при ADMA-подобной модели преэклампсии |
IL307418A (en) | 2021-05-21 | 2023-12-01 | Amgen Inc | A method for optimizing a filling recipe for a drug container |
WO2024094457A1 (en) | 2022-11-02 | 2024-05-10 | F. Hoffmann-La Roche Ag | Method for producing glycoprotein compositions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2215748C2 (ru) * | 1999-04-09 | 2003-11-10 | Сентро Де Инмунология Молекулар | Способ получения рекомбинантного эритропоэтина человека и полученный эритропоэтин, фармацевтическая композиция |
PA8536201A1 (es) * | 2000-12-29 | 2002-08-29 | Kenneth S Warren Inst Inc | Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina |
US20030072737A1 (en) * | 2000-12-29 | 2003-04-17 | Michael Brines | Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
EP1633305A2 (en) * | 2003-05-19 | 2006-03-15 | The Kenneth S. Warren Institute, Inc. | Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window |
-
2005
- 2005-07-07 EA EA200700255A patent/EA011586B1/ru not_active IP Right Cessation
- 2005-07-07 DK DK05755533T patent/DK1781697T3/da active
- 2005-07-07 AT AT05755533T patent/ATE429444T1/de active
- 2005-07-07 PL PL05755533T patent/PL1781697T3/pl unknown
- 2005-07-07 AU AU2005259689A patent/AU2005259689B2/en not_active Ceased
- 2005-07-07 WO PCT/DK2005/000477 patent/WO2006002646A2/en active Application Filing
- 2005-07-07 EP EP05755533A patent/EP1781697B1/en active Active
- 2005-07-07 CA CA002572643A patent/CA2572643A1/en not_active Abandoned
- 2005-07-07 DE DE602005014117T patent/DE602005014117D1/de active Active
- 2005-07-07 BR BRPI0513029-8A patent/BRPI0513029A/pt not_active IP Right Cessation
- 2005-07-07 MX MXPA06014742A patent/MXPA06014742A/es active IP Right Grant
- 2005-07-07 SI SI200530707T patent/SI1781697T1/sl unknown
- 2005-07-07 JP JP2007519619A patent/JP5025470B2/ja not_active Expired - Fee Related
- 2005-07-07 ES ES05755533T patent/ES2325034T3/es active Active
- 2005-07-07 PT PT05755533T patent/PT1781697E/pt unknown
-
2007
- 2007-01-02 IL IL180518A patent/IL180518A0/en unknown
- 2007-02-06 NO NO20070687A patent/NO20070687L/no not_active Application Discontinuation
-
2008
- 2008-01-10 HK HK08100325.8A patent/HK1109631A1/xx not_active IP Right Cessation
-
2009
- 2009-06-15 HR HR20090343T patent/HRP20090343T1/xx unknown
- 2009-07-14 CY CY20091100734T patent/CY1109232T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EA011586B1 (ru) | 2009-04-28 |
AU2005259689A1 (en) | 2006-01-12 |
JP5025470B2 (ja) | 2012-09-12 |
PT1781697E (pt) | 2009-06-25 |
MXPA06014742A (es) | 2007-02-16 |
CY1109232T1 (el) | 2014-07-02 |
EA200700255A1 (ru) | 2007-06-29 |
DK1781697T3 (da) | 2009-07-06 |
WO2006002646A2 (en) | 2006-01-12 |
CA2572643A1 (en) | 2006-01-12 |
PL1781697T3 (pl) | 2009-10-30 |
HK1109631A1 (en) | 2008-06-13 |
JP2008505133A (ja) | 2008-02-21 |
IL180518A0 (en) | 2007-06-03 |
NO20070687L (no) | 2007-03-27 |
BRPI0513029A (pt) | 2008-04-22 |
WO2006002646A3 (en) | 2006-04-13 |
ATE429444T1 (de) | 2009-05-15 |
AU2005259689B2 (en) | 2011-10-06 |
EP1781697B1 (en) | 2009-04-22 |
EP1781697A2 (en) | 2007-05-09 |
SI1781697T1 (sl) | 2009-08-31 |
ES2325034T3 (es) | 2009-08-24 |
DE602005014117D1 (de) | 2009-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1109631A1 (en) | Novel carbamylated epo and method for its production | |
TW200608973A (en) | Rapamycin polymorph Ⅱ and uses thereof | |
EP1638993A4 (en) | IMMUNOMODULATING COMPOSITIONS, APPLICATIONS THEREOF AND METHOD FOR THE PRODUCTION THEREOF | |
PT1913001E (pt) | (r)-n-metilnaltrexona, processos para a sua síntese e sua utilização farmacêutica | |
MX2007005221A (es) | Formas cristalinas de ascomicina y preparacion de ellas. | |
TW200505837A (en) | Novel compounds | |
HK1117746A1 (en) | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use | |
BRPI0512820A (pt) | composição de matéria, e método de revestir um metal | |
DE602006019732D1 (de) | Indolylmaleimidderivate | |
TW200745039A (en) | Isotopically substituted pantoprazole | |
TW200732410A (en) | Sprayable acoustic compositions | |
ZA200604874B (en) | Pharmaceutical compositions | |
WO2006078998A3 (en) | Methods and compositions for decreasing saliva production | |
TW200602298A (en) | Processes for the preparation of aryl-and heteroaryl-alkylsulfonyl halides | |
AP2007004223A0 (en) | Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives | |
TW200517144A (en) | Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties | |
EA200600590A1 (ru) | Фармацевтические композиции модафинила с модифицированным высвобождением | |
TW200612979A (en) | Novel carbamylated epo and method for its production | |
UA91983C2 (ru) | Новый карбамилированный эритропоэтин и способ его получения | |
MY145375A (en) | Pharmaceutical composition | |
MXPA05012363A (es) | Poliisocianatos bloqueados estables en la solidificacion. | |
EP1546310A4 (en) | IMMUNOMODULATION COMPOSITIONS, METHODS FOR PRODUCING THEM AND USES THEREOF | |
PL372933A1 (en) | Methylthiophene carboxanilides | |
TW200740366A (en) | Novel fluorescent cichlid and method for producing thereof | |
WO2005123033A3 (en) | Fine particles of cilostazol and processes for production thereof |